SBC / revenue moved 159712 bp lower
SBC / revenue changed -159712 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue changed -159712 basis points from the comparable as-filed period.
Operating cash flow changed -7.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -17.2% from the comparable as-filed period.
Free-cash-flow proxy changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed -877109 basis points from the comparable as-filed period.
Operating cash-flow margin changed +4017521 basis points from the comparable as-filed period.
Free-cash-flow margin changed +4637076 basis points from the comparable as-filed period.
Receivables / revenue changed -114660 basis points from the comparable as-filed period.
Current ratio changed +11.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.